Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markersVishal Navani, André van der Westhuizen, Hiren Mandaliya et al.|Pharmacology Research & Perspectives|2021Cited by 10
Melanoma: An immunotherapy journey from bench to bedsideVishal Navani, Nikola A. Bowden, Hiren Mandaliya et al.|Cancer treatment and research|2022Cited by 2
243 Real world exposure survival relationship of pembrolizumab in metastatic melanomaVishal Navani, André van der Westhuizen, Moira C. Graves et al.|Regular and Young Investigator Award Abstracts|2020Cited by 0
Abstract 1672: Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markersVishal Navani, André van der Westhuizen, Nikola A. Bowden et al.|Cancer Research|2021Cited by 0